FBH1
Basic information
Region (hg38): 10:5890203-5937594
Previous symbols: [ "FBXO18" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FBH1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 58 | 62 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 58 | 4 | 0 |
Variants in FBH1
This is a list of pathogenic ClinVar variants found in the FBH1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-5895074-A-G | not specified | Uncertain significance (Nov 09, 2024) | ||
10-5895109-G-T | not specified | Uncertain significance (Jul 02, 2024) | ||
10-5895113-G-A | not specified | Uncertain significance (Oct 17, 2023) | ||
10-5895121-G-A | not specified | Uncertain significance (Apr 22, 2022) | ||
10-5895122-G-A | not specified | Uncertain significance (Oct 06, 2022) | ||
10-5895140-G-A | not specified | Uncertain significance (Feb 23, 2023) | ||
10-5895180-C-G | not specified | Uncertain significance (Mar 17, 2023) | ||
10-5903025-C-T | not specified | Uncertain significance (Jul 23, 2024) | ||
10-5903035-G-A | not specified | Uncertain significance (Jan 18, 2022) | ||
10-5903059-G-A | not specified | Uncertain significance (Feb 05, 2024) | ||
10-5903070-G-C | not specified | Uncertain significance (Nov 13, 2024) | ||
10-5903166-G-A | not specified | Uncertain significance (Sep 04, 2024) | ||
10-5906037-G-A | not specified | Uncertain significance (Nov 08, 2022) | ||
10-5906037-G-T | not specified | Uncertain significance (Oct 05, 2023) | ||
10-5906046-G-A | not specified | Uncertain significance (Jun 30, 2022) | ||
10-5906088-C-T | not specified | Uncertain significance (Jun 10, 2022) | ||
10-5906090-T-G | not specified | Uncertain significance (Sep 22, 2022) | ||
10-5906097-A-G | not specified | Uncertain significance (Sep 11, 2024) | ||
10-5906100-A-T | not specified | Uncertain significance (Jul 26, 2024) | ||
10-5906193-A-T | not specified | Uncertain significance (Nov 29, 2021) | ||
10-5906207-G-C | not specified | Likely benign (Oct 29, 2021) | ||
10-5906211-C-T | not specified | Likely benign (Oct 26, 2021) | ||
10-5906258-T-G | not specified | Uncertain significance (Oct 20, 2021) | ||
10-5906285-G-A | not specified | Uncertain significance (Aug 05, 2024) | ||
10-5906289-C-G | not specified | Uncertain significance (Dec 12, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FBH1 | protein_coding | protein_coding | ENST00000379999 | 22 | 48022 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000822 | 1.00 | 125695 | 0 | 53 | 125748 | 0.000211 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.82 | 453 | 656 | 0.690 | 0.0000388 | 7211 |
Missense in Polyphen | 92 | 216.22 | 0.4255 | 2474 | ||
Synonymous | 0.493 | 250 | 260 | 0.961 | 0.0000170 | 2085 |
Loss of Function | 4.69 | 18 | 55.8 | 0.323 | 0.00000289 | 636 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000182 | 0.000181 |
Ashkenazi Jewish | 0.00160 | 0.00159 |
East Asian | 0.000817 | 0.000816 |
Finnish | 0.0000463 | 0.0000462 |
European (Non-Finnish) | 0.000106 | 0.000105 |
Middle Eastern | 0.000817 | 0.000816 |
South Asian | 0.000132 | 0.000131 |
Other | 0.000164 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: 3'-5' DNA helicase and substrate-recognition component of the SCF(FBH1) E3 ubiquitin ligase complex that plays a key role in response to stalled/damaged replication forks (PubMed:11956208, PubMed:23393192). Involved in genome maintenance by acting as an anti-recombinogenic helicase and preventing extensive strand exchange during homologous recombination: promotes RAD51 filament dissolution from stalled forks, thereby inhibiting homologous recombination and preventing excessive recombination (PubMed:17724085, PubMed:19736316). Also promotes cell death and DNA double-strand breakage in response to replication stress: together with MUS81, promotes the endonucleolytic DNA cleavage following prolonged replication stress via its helicase activity, possibly to eliminate cells with excessive replication stress (PubMed:23319600, PubMed:23361013). Plays a major role in remodeling of stalled DNA forks by catalyzing fork regression, in which the fork reverses and the two nascent DNA strands anneal (PubMed:25772361). In addition to the helicase activity, also acts as the substrate-recognition component of the SCF(FBH1) E3 ubiquitin ligase complex, a complex that mediates ubiquitination of RAD51, leading to regulate RAD51 subcellular location (PubMed:25585578). {ECO:0000269|PubMed:11956208, ECO:0000269|PubMed:17724085, ECO:0000269|PubMed:19736316, ECO:0000269|PubMed:23319600, ECO:0000269|PubMed:23361013, ECO:0000269|PubMed:25585578, ECO:0000269|PubMed:25772361}.;
- Disease
- DISEASE: Note=Defects in FBH1 are frequently observed in melanomas, resulting in increased survival in response to replicative stress. Its inactivation may play a role in oncogenic transformation. {ECO:0000269|PubMed:23466708}.;
Recessive Scores
- pRec
- 0.0981
Intolerance Scores
- loftool
- rvis_EVS
- -2.03
- rvis_percentile_EVS
- 1.68
Haploinsufficiency Scores
- pHI
- 0.151
- hipred
- Y
- hipred_score
- 0.639
- ghis
- 0.605
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Mouse Genome Informatics
- Gene name
- Fbh1
- Phenotype
Gene ontology
- Biological process
- double-strand break repair via homologous recombination;recombinational repair;DNA catabolic process, endonucleolytic;positive regulation of protein phosphorylation;DNA repair;cellular response to DNA damage stimulus;cell death;protein ubiquitination;replication fork processing;DNA duplex unwinding;negative regulation of chromatin binding;replication fork protection;response to intra-S DNA damage checkpoint signaling;positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage;negative regulation of double-strand break repair via homologous recombination
- Cellular component
- chromatin;nucleus;SCF ubiquitin ligase complex
- Molecular function
- DNA helicase activity;double-stranded DNA binding;single-stranded DNA binding;protein binding;DNA translocase activity;3'-5' DNA helicase activity;ATP-dependent 3'-5' DNA helicase activity